<HTML>
<HEAD>
<TITLE>LabOne, Inc. Form 8-K dated May 7, 2002</TITLE>
</HEAD>

<FONT SIZE=5><STRONG><P ALIGN="CENTER">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</P>
</FONT></STRONG><FONT SIZE=4><P ALIGN="CENTER">Washington, D.C. 20549</P>
</FONT><FONT SIZE=5><STRONG><P ALIGN="CENTER">FORM 8-K</P>
</FONT></STRONG><P ALIGN="CENTER">CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</P>
<P ALIGN="CENTER">Date of Report: <U>June 14, 2002</P>
</U><P ALIGN="CENTER">Commission file number: 0-16946</P>
<B><U><FONT FACE="Times,Times New Roman" SIZE=5><P ALIGN="CENTER">Lab<I>One</I>, Inc.</P>
</B></U></FONT><P ALIGN="CENTER">10101 Renner Blvd.</P>
<P ALIGN="CENTER">Lenexa, Kansas 66219</P>
<P ALIGN="CENTER">(913) 888-1770</P>
<FONT FACE="Times,Times New Roman"><P ALIGN="CENTER">Incorporated in Missouri</P>
<P ALIGN="CENTER">I.R.S. Employer Identification Number: 43-1039532</P>
</FONT><FONT FACE="Times,Times New Roman" SIZE=2><P>&nbsp;</P>
</FONT><P><HR ALIGN="RIGHT"></P>




<FONT FACE="Times,Times New Roman"><P>Item 9.&nbsp;&nbsp;Regulation FD Disclosure</P>
</FONT>
<B><P ALIGN="CENTER">Lab<I>One</I> Announces New Revolving Credit Agreement</P>
</B>
<P>Lab<I>One</I>, Inc. announced today that it has executed a revolving credit agreement with J.P. Morgan Securities Inc. and Wachovia Securities, Inc. as Co-Lead Arrangers.</P>

<P>Under the credit agreement, initial commitments are $75 million with the authorization for additional commitments increasing the facility to $100 million.  Participating banks include J.P. Morgan Chase Bank, Wachovia Bank, Wells Fargo Bank, U.S. Bank and Commerce Bank.  The proceeds of the credit agreement will be used to refinance amounts outstanding under Lab<I>One</I>'s existing credit agreement and for general corporate purposes. Lab<I>One</I> intends to use the leverage capacity made available with the new credit facility to fund future acquisitions.</P>

<B><P>Forward-looking Statements</P>
</B><P>Statements made in this press release that are not historical facts are "forward-looking statements." Forward-looking statements often can be identified by the use of forward-looking terminology, such as "believes," "expects," "may," "will," "should," "could," "intends," "plans," "estimates," "anticipates," variations there of, or similar expressions. The Company's future use of funds, results of operations, financial condition and business operations may differ materially from those expressed in these forward-looking statements. Many factors could cause actual use of funds and results to differ materially from those that may be expressed or implied in such forward-looking statements, including, but not limited to, the availability of acquisition candidates at reasonable prices, the cash generated by the Company's operations and from other financing sources, and other factors detailed from time to time in the Company's reports and registration statements filed with the Securities and Exchange Commission, including the Cautionary Statement filed as Exhibit 99 to the Company's Annual Report on Form 10-K for 2001. Investors are cautioned not to put undue reliance on any forward-looking statement.</P>

<P>&nbsp;</P>
<P>&nbsp;</P>

<P><HR ALIGN="RIGHT"></P>
<P>&nbsp;&nbsp;</P>
<I><FONT SIZE=5><P ALIGN="CENTER">Signatures</I></FONT><FONT FACE="Times,Times New Roman"> </P>
<P ALIGN="CENTER">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</P>
<P ALIGN="CENTER">&nbsp;</FONT><FONT SIZE=5>Lab<I>One</I>, Inc.</P>
</FONT>
<CENTER>
<TABLE cellSpacing=0 cellPadding=10 width=524 border=0>
  <TR>
    <TD vAlign=top width="40%">
      <P>Date:&nbsp;&nbsp;June 14, 2002</P></TD>
    <TD vAlign=center width="60%">
      <P>By <U>/s/ <I>John W. McCarty</I></U><BR>John W. McCarty
      <BR>Executive V.P. and Chief Financial Officer
  </P></TD></TR>
  <TR>
    <TD vAlign=top width="40%">
      <P>Date:&nbsp;&nbsp;June 14, 2002</P></TD>
    <TD vAlign=center width="60%">
      <P>By <U>/s/ <I>Joseph C. Benage</I></U><BR>Joseph C. Benage
      <BR>Secretary
  </P></TD></TR></TABLE></CENTER>

</BODY></HTML>
[{"type": "8-K", "sequence": "1", "filename": "htm8k06.htm", "secsgml_size_bytes": 4246}]
{"company-data": {"conformed-name": "LABONE INC/", "cik": "0000830158", "assigned-sic": "8071", "irs-number": "431039532", "state-of-incorporation": "MO", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "333-92137", "film-number": "02679673"}, "business-address": {"street1": "10101 RENNER BLVD", "street2": "P. O. BOX 7568", "city": "LENEXA", "state": "KS", "zip": "66219", "phone": "9138881770"}, "mail-address": {"street1": "10101 RENNER BLVD", "street2": "X", "city": "LENEXA", "state": "KS", "zip": "66219"}, "former-company": [{"former-conformed-name": "LAB HOLDINGS INC", "date-changed": "19980406"}, {"former-conformed-name": "SEAFIELD CAPITAL CORP", "date-changed": "19920703"}, {"former-conformed-name": "SEAFIELD CAPTIAL CORP", "date-changed": "19910520"}]}
LabOne, Inc. Form 8-K dated May 7, 2002
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report:
June 14, 2002
Commission file number: 0-16946
Lab
One
, Inc.
10101 Renner Blvd.
Lenexa, Kansas 66219
(913) 888-1770
Incorporated in Missouri
I.R.S. Employer Identification Number: 43-1039532
Item 9.  Regulation FD Disclosure
Lab
One
Announces New Revolving Credit Agreement
Lab
One
, Inc. announced today that it has executed a revolving credit agreement with J.P. Morgan Securities Inc. and Wachovia Securities, Inc. as Co-Lead Arrangers.
Under the credit agreement, initial commitments are $75 million with the authorization for additional commitments increasing the facility to $100 million.  Participating banks include J.P. Morgan Chase Bank, Wachovia Bank, Wells Fargo Bank, U.S. Bank and Commerce Bank.  The proceeds of the credit agreement will be used to refinance amounts outstanding under Lab
One
's existing credit agreement and for general corporate purposes. Lab
One
intends to use the leverage capacity made available with the new credit facility to fund future acquisitions.
Forward-looking Statements
Statements made in this press release that are not historical facts are "forward-looking statements." Forward-looking statements often can be identified by the use of forward-looking terminology, such as "believes," "expects," "may," "will," "should," "could," "intends," "plans," "estimates," "anticipates," variations there of, or similar expressions. The Company's future use of funds, results of operations, financial condition and business operations may differ materially from those expressed in these forward-looking statements. Many factors could cause actual use of funds and results to differ materially from those that may be expressed or implied in such forward-looking statements, including, but not limited to, the availability of acquisition candidates at reasonable prices, the cash generated by the Company's operations and from other financing sources, and other factors detailed from time to time in the Company's reports and registration statements filed with the Securities and Exchange Commission, including the Cautionary Statement filed as Exhibit 99 to the Company's Annual Report on Form 10-K for 2001. Investors are cautioned not to put undue reliance on any forward-looking statement.
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Lab
One
, Inc.
Date:  June 14, 2002
By
/s/
John W. McCarty
John W. McCarty
Executive V.P. and Chief Financial Officer
Date:  June 14, 2002
By
/s/
Joseph C. Benage
Joseph C. Benage
Secretary